Veterinary Medicines

Nobivac DHPPi vet. Pulver och vätska till injektionsvätska, suspension

Authorised
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Water
Download as PDF

Product identification

Medicine name:
Nobivac DHPPi vet. Pulver och vätska till injektionsvätska, suspension
Active substance:
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Water
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain 154, Live
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain Cornell, Live
    5.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain Onderstepoort, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Water
    1.00
    millilitre(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Oriola Sweden AB
  • Intervet International B.V.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 12612
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
Download